je.st
news
UPDATE 1-Britain's cost agency not ready to back Gilead hepatitis C drug
2014-06-16 22:27:05| Biotech - Topix.net
Britain's healthcare cost-effectiveness watchdog said on Monday it needed more information about Gilead Sciences' pricey new hepatitis C drug Sovaldi before deciding if it should be used on the state health service.
Tags: back
cost
update
ready
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||